Coronary artery disease in HIV infected patients

Intensive Care Medicine

Volumn 29, Issue 6, 2003, Pages 969-973

  Escaut, Lelia ^a   Monsuez, Jean Jacques ^a   Chironi, Gilles ^b   Merad, Mansouriah ^a   Teicher, Elina ^a   Smadja, Denis ^a   Simon, Alain ^b   Vittecoq, Daniel ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

Acute coronary artery disease; Highly active antiretroviral therapy; Human immunodeficiency virus 1; Hyperlipidemia; Tobacco smoking

Indexed keywords

ABCIXIMAB; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SULFAMIDE DERIVATIVE; TICLOPIDINE;

ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RESTENOSIS; SMOKING; T LYMPHOCYTE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0038466343     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-1740-0     Document Type: Article

References (28)

1. Dube MP, Sprecher D, Henry WK, Aberg JA, Torrriani FJ, Hodis HN, Schouten J, Levin J, Myers G, Zackin R, Nevin T, Currier JS (2000) Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Clin Infect Dis 31:1216-1224
2. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA (1999) Diagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidemia and diabetes mellitus: a cohort study. Lancet 353:2093-2099
3. Tsiodras S, Mantzoros C, Hammer S, Samore M (2000) Effects of protease inhibitors on hyperglycemia, hyperlipidemia and lipodystrophy: a 5-year cohort study. Arch Intern Med 160:2050-2056
4. Henry K, Melroe H, Huebsh J, Hermundson J, Levine C, Swensen L, Daley J (1998) Severe premature coronary artery disease with protease inhibitors. Lancet 351:1328
5. Behrens G, Schmidt H, Meyer D, Stoll M, Schmidt RE (1998) Vascular complications associated with the use of HIV protease inhibitors. Lancet 351:1958
6. Flynn TE, Bricker LA (1999) Myocardial infarction in HIV-infected men receiving protease inhibitors. Ann Intern Med 131:548
7. Barbaro G, Barbarini G, Pellicelli AM (2001) HIV-associated coronary arteritis in a patient with fatal myocardial infarction. N Engl J Med 344:1799-1800
8. Ryan TJ, Antman EM, Brooks NH, Califf Rm, Hilis LD, Hiratzka LF, Rapaport E, Riegel B, Russel RO, Smith EE 3rd, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A Jr, Gregoratos G, Ryan TJ, Smith SC Jr (1999) ACC/AHA Guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations. Circulation 100:1016-1030
9. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P (1999) Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-years results from 37 WHO MONICA Project populations. Lancet 353:1547-1557
10. Cambou JP, Genes N, Vaur L, Renault M, Etienne S, Ferrieres J, Danchin N (1997) Epidémiologie de l'infarctus du myocarde en France. Arch Mal Coeur Vaiss 90:1511-1519
11. Andrejak M, Gras-Champel V, Pannier M, et al (2000) Coronary events in HIV-infected patients. 8th Annual Meeting of the European Society of Pharmacovigilance, Verona
12. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V (1999) Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. Circulation 100:1481-1492
13. Marques-Vidal P, Cambou JP, Ferrieres J, Thomas D, Grenier O, Danchin N (2001) Distribution et prise en charge des facteurs de risque cardiovasculaires chez des patients coronariens: étude PREVENIR. Arch Mal Coeur Vaiss 94:673-980
14. Miller JI, Sperling LS, Agahterani A, Nell C, Weintraub WS (2001) Premature coronary artery disease: 15-year follow-up in patients under the age of forty. J Am Coll Cardiol 37:504A
15. Fallavollita JA, Brody AS, Bunnel IL, Kumar K, Canty JM (1994) Fast computed tomography detection of coronary calcification in the diagnosis of coronary artery disease: comparison with angiography in patients <50 years old. Circulation 89:285-290
16. Lapandry C (2001) Prise en charge préhospitalière de l'infarctus du myocarde en région francilienne. Arch Mal Coeur Vaiss 94 [Suppl 1]:7
17. Weintraub WS, Ghazzal ZM, Douglas JS Jr, Liberman HA, Morris DC, Cohen CL, King SB 3rd (1993) Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty. Circulation 87:831-840
18. Libby P (1995) Molecular basis of acute coronary syndromes. Circulation 92:657-671
19. Carr A, Samaras K, Chisholm DJ, Cooper DA (1998) Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidemia and insulin resistance. Lancet 352:1881-1833
20. Pierard D, Telenti A, Sudre P, Cheseaux JJ, Halfon P, Reymond MJ, Marcovina SM, Glauser MP, Nicod P, Darioli R, Mooser V (1999) Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. Circulation 100:700-705
21. Best PJM, Edwards WD, Holmes DR, Lerman A (1997) Unique coronary arteriopathy associated with human immunodeficiency virus. J Am Coll Cardiol 31 [Suppl A]:272A
22. Paton P, Tabib F, Loire R, Tete R (1993) Coronary artery lesions and human immunodeficiency virus infection. Res Virol 144:225-231
23. Chalifoux LV, Simon MA, Pauley DR, McKey JJ, Wyands MS, Ringler DJ (1992) Arteriopathy in macaques infected with simian immunodeficiency virus. Lab Invest 67:338-349
24. Zietz C, Hotz B, Sturzl M, Rauch E, Penning R, Lohrs U (1996) Aortic endothelium in HIV-1 infection: chronic injury, activation and increased leucocyte adherence. Am J Pathol 149:1887-1998
25. Monsuez JJ, Vittecoq D, Dufaux J, Vicaut E (2000) Reduced reactive hyperemia in HIV-infected patients. J AIDS 25:434-442
26. Zhou X, Nicoletti A, Elhage R, Hansson G (2000) Transfer of CD4+ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102:2919-2922
27. Mary-Krause M, Cotte L, Partisani M, Simon A, Costagliola D (2001) Impact of treatment with protease inhibitors on myocardial infarction occurrence in HIV-infected men. 8th Conference on Retroviruses and Opportunistic Infections, (abstract 657)
28. Klein D, Hurley L, Sorel M, S Sidney (2002) Do protease inhibitors increase the risk for coronary heart disease in patients with HIV1 infection. J AIDS 15:471-477